MOLECULAR BASIS OF ESSENTIAL THROMBOCYTOSIS

原发性血小板增多症的分子基础

• 批准号: 7950798
• 负责人: Wadie F Bahou
• 金额: $ 0.55万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950798
• 关键词: Blood; Blood Circulation; Blood Platelets; Blood specimen; Bone Marrow Cells; Cell Nucleus; Cells; Clinical Research; Coagulation Process; Computer Retrieval of Information on Scientific Projects Database; DNA; Diagnostic tests; Erythrocytes; Funding; Genes; Grant; Hemorrhage; Hemorrhagic Thrombocythemia; Injury; Institution; Laboratories; Leukocytes; Methods; Molecular; Myocardial Infarction; Patients; Plasma; Platelet Count measurement; Play; Procedures; Production; RNA analysis; Research; Research Personnel; Resources; Risk Assessment; Role; Sampling; Site; Source; Stroke; Tissues; Transcript; United States National Institutes of Health; Upper arm; Veins; Venipunctures; base

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Platelets are small cell fragments that circulate in the bloodstream. They play a key role in controlling bleeding by their ability to form "plugs" at sites of tissue injury. Some patients have high platelet counts that may be associated with bleeding or clotting problems that can predispose to heart attacks or stroke. The genes that control platelet production are largely unknown; their identification would allow more precise diagnostic tests, risk assessment, and potential new targets for therapy. Platelets do not have nuclei; however they do carry a set of different genes from the precursor bone marrow cells from which they originate. These gene transcripts (RNAs) are present at different abundance levels, i.e some of them are present at very high number, whereas others are very difficult to detect. We will try to use sophisticated laboratory methods to identify new platelet genes that may be associated with abnormally high platelet counts. To collect platelets for this study, we will use standard procedures that are routinely used for blood isolation. All blood samples will be obtained by venipuncture, i.e. thawing small volumes (15 to 30 mL [1-2 tablespoons]) of blood from a vein in one's arm. Blood will be used for the source of platelets for gene (RNA) analysis and white blood cells will be used for isolation of DNA. The remaining sample (plasma and red blood cells) will be properly discarded.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 血小板是在血液中循环的小细胞碎片。它们通过在组织损伤部位形成“栓塞”的能力，在控制出血方面发挥着关键作用。一些患者的血小板计数较高，可能与出血或凝血问题有关，从而容易引发心脏病或中风。控制血小板生成的基因在很大程度上是未知的；它们的鉴定将允许更精确的诊断测试、风险评估和潜在的新治疗目标。血小板没有细胞核；然而，它们确实携带了一组与它们起源的前体骨髓细胞不同的基因。这些基因转录本（RNA）以不同的丰度水平存在，即其中一些的数量非常高，而另一些则很难检测到。我们将尝试使用复杂的实验室方法来识别可能与异常高血小板计数相关的新血小板基因。 为了收集本研究的血小板，我们将使用常规用于血液分离的标准程序。所有血样均通过静脉穿刺获得，即从手臂静脉中解冻少量（15 至 30 mL [1-2 汤匙]）血​​液。血液将用作基因 (RNA) 分析的血小板来源，白细胞将用于分离 DNA。剩余的样本（血浆和红细胞）将被适当丢弃。